Assistance Publique - Hôpitaux de Paris: Lung Diseases, Interstitial trials
The registry lists 11 Lung Diseases, Interstitial studies with Assistance Publique - Hôpitaux de Paris as lead sponsor. 4 are open to participants now and 0 have results posted.
Phase 2 2Phase 3 2No phase 7(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Immunomodulatory Treatment of Interstitial Lung Disease Associated With Surfactant Related Gene VariantsNot yet recruitingNCT07443436Phase 2
- Prospective Cohort of Patients With Fibrosing Interstitial Lung Disease Admitted for Acute Respiratory FailureRecruitingNCT06855004
- Evaluation of the Reproducibility of the Automated Measurement of the Extent of ILD on Chest CTRecruitingNCT06743022Not applicable
- Physical Activity and Fibrosing Interstitial Lung DiseaseRecruitingNCT06182748Not applicable
- Digital Modeling of Thoracic CT and Pulmonary FibrosisActive, not recruitingNCT06618924
- Interest of the Use of Pulmonary Ultrasound in the Referral of Patients With or Suspected COVID-19 +CompletedNCT04335019
- MPA AUC Monitoring in Patients Receiving MMF for Diffuse Cutaneous or Pulmonary Involvement in Systemic SclerosisTerminatedNCT04244916
- Deciphering Rheumatoid Arthritis-associated Interstitial Lung Disease Pathogenesis 2Active, not recruitingNCT04227535
- Cyclophosphamide and Azathioprine vs Tacrolimus in Antisynthetase Syndrome-related Interstitial Lung DiseaseStatus unknownNCT03770663Phase 3
- Pilot Study of Pirfenidone in Pulmonary Fibrosis With Anti-myeloperoxydase AntibodiesCompletedNCT03385668Phase 2
- Cyclophosphamide Systemic Sclerosis Associated Interstitial Lung DiseaseCompletedNCT01570764Phase 3